-1,5SD) 5 0 Weight deficiency (> -1,5SD) 47 0 Conclusion: Only 1 in each 57 patients from risk groups of coeliac disease was EMA-positive. The strategy of EMA for all patients from risk groups as a diagnostic test for CD is expensive, with a cost of 3705 PZL (926US$) per patient assessed. Further studies are required to evaluate the cost/effectivness ratio of the selective and mass screening for CD. " v:shapes="_x0000_s1026">2327